Current knowledge of foot-and-mouth disease

Oh, Yoon-I

  • Published : 20081200

Abstract

Keywords

References

  1. Alexandersen, S., Brotherhood, I. and Donaldson, A. I. Natural aerosol transmission of footand- mouth disease virus to pigs: minimal infectious dose for strain O1 Lausanne. Epidemiol Infect, 2002, 128, 301-312
  2. Alexandersen, S. and Donaldson, A. I. Further studies to quantify the dose of natural aerosols of foot-and-mouth disease virus for pigs. Epidemiol Infect, 2002, 128, 313-323
  3. Alexandersen, S. and Mowat, N. Foot-and-mouth disease: host range and pathogenesis. Curr Top Microbiol Immunol, 2005, 288, 9-42 https://doi.org/10.1007/3-540-27109-0_2
  4. Alexandersen, S., Zhang, Z., Donaldson, A. I. and Garland, A. J. The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol, 2003, 129, 1-36 https://doi.org/10.1016/S0021-9975(03)00041-0
  5. Barnett, P. V., Samuel, A. R. and Statham, R. J. The suitability of the 'emergency' foot-andmouth disease antigens held by the International Vaccine Bank within a global context. Vaccine, 2001, 19, 2107-2117 https://doi.org/10.1016/S0264-410X(00)00399-6
  6. Barnett, P. V., Statham, R. J., Vosloo, W. and Haydon, D. T. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine, 2003, 21, 3240-3248 https://doi.org/10.1016/S0264-410X(03)00219-6
  7. Beck, E. and Strohmaier, K. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J Virol, 1987, 61, 1621-1629
  8. Becker, Y. Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV) -a point of view. Virus Genes, 1994, 8, 199-214 https://doi.org/10.1007/BF01703078
  9. Brehm, K. E., Kumar, N., Thulke, H. H. and Haas, B. High potency vaccines induce protection against heterologous challenge with footand- mouth disease virus. Vaccine, 2008, 26, 1681-1687 https://doi.org/10.1016/j.vaccine.2008.01.038
  10. Brown, F. New approaches to vaccination against foot-and-mouth disease. Vaccine, 1992, 10, 1022-1026 https://doi.org/10.1016/0264-410X(92)90111-V
  11. Brown, F. Stepping stones in foot-and-mouth research: a personal view. In Foot and Mouth Disease, Current Perspectives, pp. 1-17, Horizon Bioscience, Norfolk, 2004
  12. Childerstone, A. J., Cedillo-Baron, L., Foster- Cuevas, M. and Parkhouse, R. M. Demonstration of bovine CD8+ T-cell responses to foot-and-mouth disease virus. The Journal of General Virology, 1999, 80 ( Pt 3), 663-669 https://doi.org/10.1099/0022-1317-80-3-663
  13. Clavijo, A., Wright, P. and Kitching, P. Developments in diagnostic techniques for differentiating infection from vaccination in footand- mouth disease. Vet J, 2004, 167, 9-22 https://doi.org/10.1016/S1090-0233(03)00087-X
  14. Collen, T. Foot-and-mouth disease virus (aphthovirus): viral T cell epitopes. In Cell-Mediated Immunity in Ruminants, pp. 173-197, CRC press Inc., Boca Raton, 1994
  15. Davies, G. Foot and mouth disease. Res Vet Sci, 2002, 73, 195-199 https://doi.org/10.1016/S0034-5288(02)00105-4
  16. Dawe, P. S., Flanagan, F. O., Madekurozwa, R. L., Sorensen, K. J., Anderson, E. C., Foggin, C. M., Ferris, N. P. and Knowles, N. J. Natural transmission of foot-and-mouth disease virus from African buffalo (Syncerus caffer) to cattle in a wildlife area of Zimbabwe. Vet Rec, 1994, 134, 230-232 https://doi.org/10.1136/vr.134.10.230
  17. Dawe, P. S., Sorensen, K., Ferris, N. P., Barnett, I. T., Armstrong, R. M. and Knowles, N. J. Experimental transmission of foot-andmouth disease virus from carrier African buffalo (Syncerus caffer) to cattle in Zimbabwe. Vet Rec, 1994, 134, 211-215 https://doi.org/10.1136/vr.134.9.211
  18. Doel, T. R. FMD vaccines. Virus Res, 2003, 91, 81-99 https://doi.org/10.1016/S0168-1702(02)00261-7
  19. Doel, T. R. Natural and vaccine induced immunity to FMD. Curr Top Microbiol Immunol, 2005, 288, 103-131 https://doi.org/10.1007/3-540-27109-0_5
  20. Donaldson, A. I. and Doel, T. R. Foot-andmouth disease: the risk for Great Britain after 1992. Vet Rec, 1992, 131, 114-120 https://doi.org/10.1136/vr.131.6.114
  21. Gibbs, E. P. Emerging zoonotic epidemics in the interconnected global community. Vet Rec, 2005, 157, 673-679 https://doi.org/10.1136/vr.157.22.673
  22. Golde, W. T., Pacheco, J. M., Duque, H., Doel, T., Penfold, B., Ferman, G. S., Gregg, D. R. and Rodriguez, L. L. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response. Vaccine, 2005, 23, 5775-5782 https://doi.org/10.1016/j.vaccine.2005.07.043
  23. Goris, N., Merkelbach-Peters, P., Diev, V. I., Verloo, D., Zakharov, V. M., Kraft, H. P. and De Clercq, K. European pharmacopoeia footand- mouth disease vaccine potency testing in cattle: Between test variability and its consequences. Vaccine, 2007, 25, 3373-3379 https://doi.org/10.1016/j.vaccine.2006.12.049
  24. Grubman, M. J. and Baxt, B. Foot-and-mouth disease. Clin Microbiol Rev, 2004, 17, 465-493 https://doi.org/10.1128/CMR.17.2.465-493.2004
  25. Kitching, P., Hammond, J., Jeggo, M., Charleston, B., Paton, D., Rodriguez, L. and Heckert, R. Global FMD control--is it an option? Vaccine, 2007, 25, 5660-5664 https://doi.org/10.1016/j.vaccine.2006.10.052
  26. Kitching, R. P. Diagnosis and control of footand- mouth disease. In Foot and Mouth Disease, Current Perspectives, pp. 411-424, Horizon Bioscience, Wymondham, England, 2004
  27. Kitching, R. P. Global epidemiology and prospects for control of foot-and-mouth disease. Curr Top Microbiol Immunol, 2005, 288, 133-148 https://doi.org/10.1007/3-540-27109-0_6
  28. Mahy, B. W. Overview of foot-and-mouth disease and its impact as a re-emergent viral infection. In Foot-and-Mouth Disease Current perspectives, pp. 437-446, Horizon Bioscience, Norfolk, 2004
  29. McCullough, K. C., Bruckner, L., Schaffner, R., Fraefel, W., Muller, H. K. and Kihm, U. Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection. Vet Microbiol, 1992, 30, 99-112 https://doi.org/10.1016/0378-1135(92)90106-4
  30. Oh, Y. Correlating vaccine-induced protection with cellular immune responses to foot-andmouth disease [PhD Thesis], Bristol University, 2008
  31. Oh, Y., Charleston, B., Paton, D., Park, J. H., Barnet, P. V., Joo, Y. S. and Parida, S. Importance of cell mediated immunity for protection against foot and mouth disease. Session of the Research Group of the Standing Technical Committee of EUFMD, Appendix 38, p. 230- 239, Paphos, Cyprus, 2006
  32. Parida, S., Anderson, J., Cox, S. J., Barnett, P. V. and Paton, D. J. Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance. Vaccine, 2006, 24, 1107-1116 https://doi.org/10.1016/j.vaccine.2005.09.006
  33. Parida, S., Cox, S. J., Reid, S. M., Hamblin, P., Barnett, P. V., Inoue, T., Anderson, J. and Paton, D. J. The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease. Vaccine, 2005, 23, 5186-5195 https://doi.org/10.1016/j.vaccine.2005.06.012
  34. Parida, S., Fleming, L., Oh, Y., Mahapatra, M., Hamblin, P., Gloster, J., Doel, C., Gubbins, S. and Paton, D. J. Reduction of foot-and-mouth disease (FMD) virus load in nasal excretions, saliva and exhaled air of vaccinated pigs following direct contact challenge. Vaccine, 2007, 25, 7806-7817 https://doi.org/10.1016/j.vaccine.2007.08.058
  35. Parida, S., Oh, Y., Reid, S. M., Cox, S. J., Statham, R. J., Mahapatra, M., Anderson, J., Barnett, P. V., Charleston, B. and Paton, D. J. Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV. Vaccine, 2006, 24, 964-969 https://doi.org/10.1016/j.vaccine.2005.08.108
  36. Pay, T. W. and Hingley, P. J. The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattle. Dev Biol Stand, 1986, 64, 153-161
  37. Pay, T. W. and Hingley, P. J. Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines. Vaccine, 1987, 5, 60-64 https://doi.org/10.1016/0264-410X(87)90011-9
  38. Pay, T. W. and Hingley, P. J. Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge. Vaccine, 1992, 10, 699-706 https://doi.org/10.1016/0264-410X(92)90092-X
  39. Saiz, J. C., Rodriguez, A., Gonzalez, M., Alonso, F. and Sobrino, F. Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. The Journal of General Virology, 1992, 73 (Pt 10), 2601-2607 https://doi.org/10.1099/0022-1317-73-10-2601
  40. Saiz, M., Nunez, J. I., Jimenez-Clavero, M. A., Baranowski, E. and Sobrino, F. Foot-andmouth disease virus: biology and prospects for disease control. Microbes Infect, 2002, 4, 1183-1192 https://doi.org/10.1016/S1286-4579(02)01644-1
  41. Salt, J. S. The carrier state in foot and mouth disease-an immunological review. Br Vet J, 1993, 149, 207-223 https://doi.org/10.1016/S0007-1935(05)80168-X
  42. Sanz-Parra, A., Jimenez-Clavero, M. A., Garcia- Briones, M. M., Blanco, E., Sobrino, F. and Ley, V. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology, 1999, 259, 129-134 https://doi.org/10.1006/viro.1999.9717
  43. Stone, R. Foot-and-mouth disease. Report urges U.K. to vaccinate herds. Science, 2002, 297, 319-321
  44. Sutmoller, P., Gomes, I. and Astudillo, V. M. Potency estimation of FMD vaccines according to antibody assay results. Boletin del Centro Panamericano Fiebre Aftosa, 1984, 45-50, 31-34
  45. Sutmoller, P., McVicar, J. W. and Cottral, G. E. The epizootiological importance of footand- mouth disease carriers. I. Experimentally produced foot-and-mouth disease carriers in susceptible and immune cattle. Arch Gesamte Virusforsch, 1968, 23, 227-235 https://doi.org/10.1007/BF01241895
  46. Thomson, G. Foot and mouth disease: facing the new dilemmas. Rev Sci Tech, 2002, 21, 425-428
  47. Valarcher, J. F., Leforban, Y., Rweyemamu, M., Roeder, P. L., Gerbier, G., Mackay, D. K., Sumption, K. J., Paton, D. J. and Knowles, N. J. Incursions of foot-and-mouth disease virus into Europe between 1985 and 2006. Transbound Emerg Dis, 2008, 55, 14-34 https://doi.org/10.1111/j.1865-1682.2007.01010.x
  48. Van Lierop, M. J., Wagenaar, J. P., van Noort, J. M. and Hensen, E. J. Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J Virol, 1995, 69, 4511-4514